CHICAGO, IL / ACCESS Newswire / April 16, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome a leading ...

Strengthening a Doctor-Led Network Rooted in Clinical Excellence and Shared Values CHICAGO, IL / ACCESS Newswire / April 16, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed ...

MetaVia (MTVA) announced positive results from the 4-week multiple ascending dose Part 2 of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin analog agonist that functions as a ...

The Phase 1 trial was a randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple ...

The Company anticipates sharing initial data for the CT-95 Phase 1 trial in mid-2026. This milestone marks Context’s second active clinical trial, following the dosing of the first patient in ...

Perspective, Therapeutics announced that the first patient was dosed in a new cohort of a Phase 1/2a trial evaluating the safety of 212PbVMT01, a targeted alpha-particle therapy, as monotherapy in ...

The randomized, double-blind, placebo-controlled Phase 1 single/multiple ascending dose (SAD/MAD) study evaluated the safety, tolerability and pharmacokinetics of oral CVN293 in 72 healthy adult ...